title: Hydralazine-induced lupus erythematosus: what is the mechanism?
authors.forename: Ji Young
authors.initials: JY
authors.lastname: Oh
authors.forename: Se Jin
authors.initials: SJ
authors.lastname: Park
authors.forename: Jae Ii
authors.initials: JI
authors.lastname: Shin
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage / Q000009:adverse effects; D006973:Hypertension / Q000188:drug therapy; D016753:Interleukin-10 / Q000276:immunology*; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced / Q000276:immunology
chemical_list: D000959:Antihypertensive Agents; D016753:Interleukin-10; D006830:Hydralazine